Hepatic Regeneration in Cirrhosis

Area of Science:

• Hepatology and Regenerative Medicine
• Stem Cell Biology and Therapeutics

Background:

• End-stage liver disease involves significant hepatocyte death, leading to decompensation and organ failure.
• Cirrhosis results from functional hepatocyte loss and excessive scarring, with limited self-renewal capacity.
• Orthotropic liver transplantation is curative but limited by donor organ availability and lifelong immunosuppression risks.

Purpose of the Study:

• To investigate the therapeutic potential of hepatic progenitor cells and bone marrow-derived stem cells in liver regeneration.
• To explore cell-based therapies as an alternative to liver transplantation for advanced cirrhosis.

Main Methods:

• Characterizing the role of hepatic progenitor cells and bone marrow-derived stem cells in liver regeneration.
• Developing techniques for cell proliferation, differentiation, and storage for therapeutic applications.
• Evaluating the functionality of transplanted cells for clinical use.

Main Results:

• Significant research advancements over two decades have refined cell-based therapy techniques.
• Understanding of cell functionality for clinical applications has been improved.
• Cell-based therapies are still in experimental stages, requiring further clinical trials.

Conclusions:

• Cell-based therapies hold promise for treating end-stage liver disease by aiding liver regeneration.
• Further research and clinical trials are essential to establish the efficacy and safety of these experimental treatments.
• The focus is on differentiating various cell sources into functional liver cells or using growth factors for ex-vivo expansion.